Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia (original) (raw)
Individualizing Risk of Multidrug-Resistant Pathogens in Community-Onset Pneumonia
Marco Falcone, Mario Venditti, Maria Scarpellini, Roberto Cangemi, Annarita Vestri, Gloria Taliani, Giuliano Bertazzoni
PloS one, 2015
View PDFchevron_right
Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization
Diego Viasus
Clinical Microbiology and Infection, 2011
View PDFchevron_right
Risk Factors Associated with Potentially Antibiotic-Resistant Pathogens in Community-Acquired Pneumonia
Miquel Ferrer
Annals of the American Thoracic Society, 2015
View PDFchevron_right
Risk factors for infection with multidrug-resistant bacteria in non-ventilated patients with hospital-acquired pneumonia
Juliana Sartori
Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia
View PDFchevron_right
A New Strategy for Healthcare-Associated Pneumonia: A 2-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-Resistant Pathogens to Select Initial Empiric Therapy
Michael Niederman
Clinical Infectious Diseases, 2013
View PDFchevron_right
Pneumonia Acquired in the Community Through Drug-Resistant Streptococcus pneumoniae
ANTONIO KOSTURAKIS MARTINEZ
American Journal of Respiratory and Critical Care Medicine, 1999
View PDFchevron_right
Intermediate risk of multidrug-resistant organisms in patients who admitted intensive care unit with healthcare-associated pneumonia
Hongyeul Lee
The Korean Journal of Internal Medicine, 2016
View PDFchevron_right
International prevalence and risk factors evaluation for drug-resistant Streptococcus pneumoniae pneumonia
Nilam Soni
Journal of Infection, 2019
View PDFchevron_right
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter- Cohort Study Using Risk Factors for Multidrug Resistant Pathogens To Select Initial Empiric Therapy
Michael Niederman
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018
View PDFchevron_right
Risk Factors for Multidrug-Resistant Pneumococcal Pneumonia
Felipe Rodríguez Castro
Infectious Diseases in Clinical Practice, 2008
View PDFchevron_right
Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective
Catia Cilloniz
Thorax, 2013
View PDFchevron_right
Community-Acquired Pneumonia with Risk for Drug-Resistant Pathogens
Nancy Nix
Southern Medical Journal, 2013
View PDFchevron_right
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project
Martin Cetron
Diagnostic Microbiology and Infectious Disease, 2005
View PDFchevron_right
Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia
Marco Mantero, Francesco Blasi, Roberto Cosentini
Clinical Infectious Diseases, 2012
View PDFchevron_right
Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital
Alfian Nur Rosyid
Infection and Drug Resistance, 2019
View PDFchevron_right
Increasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Arthur Reingold
New England Journal of Medicine, 2000
View PDFchevron_right
Multidrug-Resistant Infections Among Hospitalized Adults With Community-Acquired Pneumonia In An Indonesian Tertiary Referral Hospital
purwantyastuti ascobat
Infection and Drug Resistance, 2019
View PDFchevron_right
Predicting antibiotic resistance to community‐acquired pneumonia antibiotics in culture‐positive patients with healthcare‐associated pneumonia
Vincent Fan
Journal of Hospital Medicine, 2011
View PDFchevron_right
Multivariate Analysis of Risk Factors for Infection Due to Penicillin‐Resistant and Multidrug‐ResistantStreptococcus pneumoniae: A Multicenter Study
JOSE ANTONIO GIRON GONZALEZ
Clinical Infectious Diseases, 1997
View PDFchevron_right
Predictive Performance of Risk Factors for Multidrug-Resistant Pathogens in Nosocomial Pneumonia
Miquel Ferrer
Annals of the American Thoracic Society, 2020
View PDFchevron_right
Bacterial pneumonia associated with multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19
D. Hammoudi
F1000Research
View PDFchevron_right
Defining the Public Health Impact of Drug-Resistant Streptococcus pneumoniae: Report of a Working Group
Martin Cetron
PsycEXTRA Dataset
View PDFchevron_right
Variability in Antibiotic Prescribing for Community-Acquired Pneumonia
Kristen Feemster
Pediatrics, 2017
View PDFchevron_right
Geographically-based evaluation of multidrug resistance trends among Streptococcus pneumoniae in the USA: findings of the FAST surveillance initiative (2003–2004)
Glenn Tillotson
International Journal of Antimicrobial Agents, 2006
View PDFchevron_right
Community-acquired Pneumonia in North American Emergency Departments: Drug Resistance and Treatment Success with Clarithromycin
Marco Sivilotti, Edwin Boudreaux
Academic Emergency Medicine, 2007
View PDFchevron_right
Factors Associated with Multidrug-Resistant Pathogens in Community-Acquired Pneumonia Patients Hospitalized in a Provincial Teaching Hospital in Indonesia
Arto Y Soeroto
Shiraz E-Medical Journal, 2020
View PDFchevron_right
Prevalence and risk factors for Enterobacteriaceae in patients hospitalized with community‐acquired pneumonia
bertrand hugo mbatchou ngahane
Respirology, 2019
View PDFchevron_right